17 results on '"Van Es, Michael A."'
Search Results
2. Epidemiology of paediatric moderate and severe traumatic brain injury in the Netherlands.
- Author
-
Jochems, Denise, van Rein, Eveline, Niemeijer, Menco, van Heijl, Mark, van Es, Michael A., Nijboer, Tanja, Leenen, Luke P.H., Houwert, Roderick M., and van Wessem, Karlijn J.P.
- Subjects
BRAIN injuries ,PEDIATRICS ,CHILD mortality ,AGE groups ,CYCLING accidents - Abstract
Traumatic brain injury (TBI) is the main cause of death in children around the world. The last Dutch epidemiological study described the incidence over 10 years ago. Mechanism of injury seems to change with the age of the child, therefore it is important to appreciate different age groups. To be able to lower the impact of childhood TBI, an understanding of current incidence, mechanism of injury and outcome is necessary. A nationwide retrospective cohort study was conducted. The Dutch National Trauma Database was used to identify all patients 18 years and younger who were admitted to a Dutch hospital with moderate-severe TBI (Abbreviated Injury Score≥3) in the Netherlands, from January 2015 until December 2017. Subanalyses were done for different age groups. In total, 1413 patients were included, of whom 5% died. The incidence rate of moderate-severe TBI was 14/100,000 person years. Median age was 10.4 years. Largest age group was patients <5 years, incidence rate was highest in patients ≥16 years. Falls were more common than road traffic accidents (RTA), but RTAs occurred far more frequently amongst children over 10. RTAs predominantly consisted of bicycle accidents. Mortality rates increased from youngest to oldest age groups, as did the chances of a Glasgow Outcome Scale score of 3. Paediatric moderate-severe TBI represents a significant problem in the Netherlands. Falls are the most common mechanism of injury amongst younger children and RTAs amongst older children. Unique for the Netherlands is the vast amount of bicycle accident related injuries. • Traumatic brain injury main cause of death in children globally. • Incidence rate in the Netherlands 14/100,000 person years from January 2015 until December 2017. • 5% of these children died, mortality rates increase with age as did chances of being dependent on others in daily life. • Falls were the most common trauma mechanism, followed by road traffic accidents. • Bicycle accidents were by far the most common amongst road traffic accidents. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Distal spinal muscular atrophy featured by predominant calf muscle involvement in VRK1 associated disease – Case series and review
- Author
-
Demaegd, Koen, Brilstra, Eva H., Hoogendijk, Jessica E., de Bie, Charlotte I., de Pagter, Mirjam S., van Hecke, Wim, Mühlebner, Angelika, van Es, Michael A., Milone, Margherita, and van Rheenen, Wouter
- Published
- 2022
- Full Text
- View/download PDF
4. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study
- Author
-
van Es, Michael A, Van Vught, Paul W, Blauw, Hylke M, Franke, Lude, Saris, Christiaan G, Andersen, Peter M, Van Den Bosch, Ludo, de Jong, Sonja W, van 't Slot, Ruben, Birve, Anna, Lemmens, Robin, de Jong, Vianney, Baas, Frank, Schelhaas, Helenius J, Sleegers, Kristel, Van Broeckhoven, Christine, Wokke, John HJ, Wijmenga, Cisca, Robberecht, Wim, and Veldink, Jan H
- Subjects
- *
AMYOTROPHIC lateral sclerosis , *NEURONS , *SPINAL cord , *BLOOD , *APOPTOSIS - Abstract
Summary: Background: Amyotrophic lateral sclerosis (ALS) is a devastating disease characterised by progressive degeneration of motor neurons in the brain and spinal cord. ALS is thought to be multifactorial, with both environmental and genetic causes. Our aim was to identify genetic variants that predispose for sporadic ALS. Methods: We did a three-stage genome-wide association study in 461 patients with ALS and 450 controls from The Netherlands, using Illumina 300K single-nucleotide polymorphism (SNP) chips. The SNPs that were most strongly associated with ALS were analysed in a further 876 patients and 906 controls in independent sample series from The Netherlands, Belgium, and Sweden. We also investigated the possible pathological functions of associated genes using expression data from whole blood of patients with sporadic ALS and of control individuals who were included in the genome-wide association study. Findings: A genetic variant in the inositol 1,4,5-triphosphate receptor 2 gene (ITPR2) was associated with ALS (p=0·012 after Bonferroni correction). Combined analysis of all samples (1337 patients and 1356 controls) confirmed this association (p=3·28×10−6, odds ratio 1·58, 95% CI 1·30–1·91). ITPR2 expression was greater in the peripheral blood of 126 ALS patients than in that of 126 healthy controls (p=0·00016). Interpretation: Genetic variation in ITPR2 is a susceptibility factor for ALS. ITPR2 is a strong candidate susceptibility gene for ALS because it is involved in glutamate-mediated neurotransmission, is one of the main regulators of intracellular calcium concentrations, and has an important role in apoptosis. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
5. Mutational analysis of TARDBP in Parkinson's disease
- Author
-
van Blitterswijk, Marka, van Es, Michael A., Verbaan, Dagmar, van Hilten, Jacobus J., Scheffer, Hans, van de Warrenburg, Bart P., Veldink, Jan H., and van den Berg, Leonard H.
- Subjects
- *
GENETIC mutation , *PARKINSON'S disease patients , *DNA-binding proteins , *FRONTOTEMPORAL dementia , *AMYOTROPHIC lateral sclerosis - Abstract
Abstract: Mutations in TAR DNA-binding protein (TARDBP) are associated with heterogenic phenotypes, including amyotrophic lateral sclerosis, frontotemporal dementia, and Parkinson''s disease. In this study, we investigated the presence of TARDBP mutations in a cohort of 429 Dutch patients with Parkinson''s disease. Though we detected 1 silent mutation, p.S332S, no missense mutations were present in our cohort. Our findings, therefore, demonstrate that TARDBP mutations do not appear to contribute to the pathogenesis of Parkinson''s disease in The Netherlands. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
6. VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient
- Author
-
van Blitterswijk, Marka, van Es, Michael A., Koppers, Max, van Rheenen, Wouter, Medic, Jelena, Schelhaas, Helenius J., van der Kooi, Anneke J., de Visser, Marianne, Veldink, Jan H., and van den Berg, Leonard H.
- Subjects
- *
GENETICS of amyotrophic lateral sclerosis , *GENETIC mutation , *COHORT analysis , *MEMBRANE proteins , *CHROMOSOMES , *OPEN reading frames (Genetics) - Abstract
Abstract: Previously, we have reported amyotrophic lateral sclerosis (ALS) families with multiple mutations in major ALS-associated genes. These findings provided evidence for an oligogenic basis of ALS. In our present study, we screened a cohort of 755 sporadic ALS patients, 111 familial ALS patients (97 families), and 765 control subjects of Dutch descent for mutations in vesicle-associated membrane protein B (VAPB). We have identified 1 novel VAPB mutation (p.V234I) in a familial ALS patient known to have a chromosome 9 open reading frame 72 (C9orf72) repeat expansion. This p.V234I mutation was absent in control subjects, located in a region with high evolutionary conservation, and predicted to have damaging effects. Taken together, these findings provide additional evidence for an oligogenic basis of ALS. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
7. Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen
- Author
-
Blauw, Hylke M, Veldink, Jan H, van Es, Michael A, van Vught, Paul W, Saris, Christiaan GJ, van der Zwaag, Bert, Franke, Lude, Burbach, J Peter H, Wokke, John H, Ophoff, Roel A, and van den Berg, Leonard H
- Subjects
- *
AMYOTROPHIC lateral sclerosis , *NEURODEGENERATION , *NEURONS , *GENETIC polymorphisms , *PHENOTYPES , *GENETICS - Abstract
Summary: Background: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterised by the selective death of motor neurons in the brain and spinal cord. Genetic risk factors have been implicated in susceptibility to ALS. Like single nucleotide polymorphisms (SNPs), copy-number variants (CNVs) are a source of genetic variation that have important effects on gene expression and disease phenotypes, and our aim was to identify CNVs that predispose to sporadic ALS. Methods: We did a genome-wide screen for CNVs by analysis of Illumina 317K SNP arrays for 406 patients with sporadic ALS and 404 controls. We examined CNVs for association with ALS, and used the Kyoto Encyclopedia of Genes and Genomes database and the Gene Ontology database to investigate the functionality of genes that were deleted exclusively in patients with ALS. Findings: We detected 2328 CNVs in 810 individuals. No CNV locus was significantly associated with sporadic ALS. 406 genes were duplicated or deleted exclusively in patients with ALS and have not been reported in previous studies of CNVs. Of the 390 genes heterozygously deleted in patients with sporadic ALS, 155 (40%) deletions were recorded exclusively in patients. By contrast, of the 323 genes heterozygously deleted in control participants, only 51 (16%) were exclusive to the controls (p=2·15×10−12 for difference between groups). Products of the genes deleted specifically in patients with sporadic ALS include proteins involved in oxidative phosphorylation, regulation of the actin cytoskeleton, and interactions between cytokines and their receptors. Interpretation: Common CNVs in the regions of the genome represented on the SNP array are unlikely to be associated with sporadic ALS. However, the high number of genes deleted specifically in patients with ALS strongly suggests that multiple rare deletions might have an important role in ALS pathogenesis. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
8. Rare and common paraoxonase gene variants in amyotrophic lateral sclerosis patients
- Author
-
van Blitterswijk, Marka, Blokhuis, Anna, van Es, Michael A., van Vught, Paul W.J., Rowicka, Paulina A., Schelhaas, Helenius J., van der Kooi, Anneke J., de Visser, Marianne, Veldink, Jan H., and van den Berg, Leonard H.
- Subjects
- *
AMYOTROPHIC lateral sclerosis , *PARAOXONASE , *GENETIC polymorphisms , *META-analysis , *GENETIC mutation , *MEDICAL care , *PATIENTS - Abstract
Abstract: Polymorphisms in the paraoxonase family (PON) have been reported in patients with amyotrophic lateral sclerosis (ALS), but a recent meta-analysis did not show a clear association. Recently, PON mutations have also been identified in ALS patients. In this study, we assessed the frequency of PON variants in 1118 sporadic ALS patients, 93 familial ALS patients, and 1240 control subjects of Dutch descent. We identified PON mutations in 1.4% of sporadic ALS patients, 2.1% of familial ALS patients, and 2.5% of control subjects. There were no significant differences in mutational burden for rare variants or in allele frequencies of polymorphisms between patients and control subjects. Thus, this study does not support the premise that mutations or polymorphisms in PON contribute to ALS susceptibility. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
9. Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients
- Author
-
van Blitterswijk, Marka, van Vught, Paul W.J., van Es, Michael A., Schelhaas, Helenius J., van der Kooi, Anneke J., de Visser, Marianne, Veldink, Jan H., and van den Berg, Leonard H.
- Subjects
- *
AMYOTROPHIC lateral sclerosis , *GENETIC mutation , *JAPANESE people , *FAMILIAL diseases , *GENETIC polymorphisms , *DISEASE progression , *COHORT analysis , *PATIENTS , *DISEASES - Abstract
Abstract: Optineurin (OPTN) mutations have been reported in a cohort of Japanese patients with familial (FALS) and sporadic (SALS) amyotrophic lateral sclerosis. In Caucasian patients, OPTN mutations have been identified in FALS patients, but were not detected in a cohort of 95 SALS patients. Moreover, single nucleotide polymorphisms (SNPs) in OPTN that could raise amyotrophic lateral sclerosis (ALS) susceptibility have not been investigated. Therefore, we screened a large Dutch cohort of 1191 patients with SALS, 94 patients with FALS, and 1415 control subjects for mutations and SNPs in OPTN. We identified 1 novel nonsense mutation (Q165X) and 1 unreported missense mutation (Q454E) in individual SALS patients. These patients demonstrated rapid disease progression with an average survival of 24.5 months. No heterozygous or homozygous OPTN mutations were identified in our cohort of FALS patients. SNP analysis did not reveal significant differences between ALS patients and control subjects. Therefore, variations in OPTN appear to be a rare cause of rapidly progressive SALS in the Netherlands. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
10. Polymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosis
- Author
-
Bogaert, Elke, Goris, An, Van Damme, Philip, Geelen, Veerle, Lemmens, Robin, van Es, Michael A., van den Berg, Leonard H., Sleegers, Kristel, Verpoorten, Nathalie, Timmerman, Vincent, De Jonghe, Peter, Van Broeckhoven, Christine, Traynor, Bryan J., Landers, John E., Brown, Robert H., Glass, Jonathan D., Al-Chalabi, Ammar, Shaw, Christopher E., Birve, Anna, and Andersen, Peter M.
- Subjects
- *
GENETIC polymorphisms , *AMYOTROPHIC lateral sclerosis , *NEURONS , *GLUTAMATE receptors , *CALCIUM ions , *GENETIC mutation , *GENETIC code - Abstract
Abstract: Excitotoxicity is thought to play a pathogenic role in amyotrophic lateral sclerosis (ALS). Excitotoxic motor neuron death is mediated through the Ca2+-permeable α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-type of glutamate receptors and Ca2+ permeability is determined by the GluR2 subunit. We investigated whether polymorphisms or mutations in the GluR2 gene (GRIA2) predispose patients to ALS. Upon sequencing 24 patients and 24 controls no nonsynonymous coding variants were observed but 24 polymorphisms were identified, 9 of which were novel. In a screening set of 310 Belgian ALS cases and 794 healthy controls and a replication set of 3157 cases and 5397 controls from 6 additional populations no association with susceptibility, age at onset, or disease duration was observed. We conclude that polymorphisms in the GluR2 gene (GRIA2) are not a major contributory factor in the pathogenesis of ALS. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
11. Chromosome 9p21 in amyotrophic lateral sclerosis: the plot thickens
- Author
-
Daoud, Hussein, Belzil, Véronique, Dion, Patrick A, Rouleau, Guy A, Shatunov, Aleksey, Mok, Kin, Newhouse, Stephen, Weale, Michael E, Smith, Bradley, Vance, Caroline, Johnson, Lauren, Veldink, Jan H, van Es, Michael A, van den Berg, Leonard H, Robberecht, Wim, Van Damme, Philip, Hardiman, Orla, Farmer, Anne E, Lewis, Cathryn M, and Butler, Amy W
- Subjects
- *
AMYOTROPHIC lateral sclerosis , *CHROMOSOMES , *COMPARATIVE studies , *GENETIC polymorphisms , *INTERNATIONAL relations , *LONGITUDINAL method , *RESEARCH methodology , *MEDICAL cooperation , *RESEARCH , *RESEARCH funding , *EVALUATION research , *CASE-control method , *FRONTOTEMPORAL dementia , *SEQUENCE analysis - Abstract
Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of motor neurons that results in progressive weakness and death from respiratory failure, commonly within about 3 years. Previous studies have shown association of a locus on chromosome 9p with ALS and linkage with ALS-frontotemporal dementia. We aimed to test whether this genomic region is also associated with ALS in an independent set of UK samples, and to identify risk factors associated with ALS in a further genome-wide association study that combined data from the independent analysis with those from other countries.Methods: We collected samples from patients with sporadic ALS from 20 UK hospitals and obtained UK control samples from the control groups of the Depression Case Control study, the Bipolar Affective Case Control Study, and the British 1958 birth cohort DNA collection. Genotyping of DNA in this independent analysis was done with Illumina HumanHap550 BeadChips. We then undertook a joint genome-wide analysis that combined data from the independent set with published data from the UK, USA, Netherlands, Ireland, Italy, France, Sweden, and Belgium. The threshold for significance was p=0·05 in the independent analysis, because we were interested in replicating a small number of previously reported associations, whereas the Bonferroni-corrected threshold for significance in the joint analysis was p=2·20×10(-7)Findings: After quality control, samples were available from 599 patients and 4144 control individuals in the independent set. In this analysis, two single nucleotide polymorphisms in a locus on chromosome 9p21.2 were associated with ALS: rs3849942 (p=2·22×10(-6); odds ratio [OR] 1·39, 95% CI 1·21-1·59) and rs2814707 (p=3·32×10(-6); 1·38, 1·20-1·58). In the joint analysis, which included samples from 4312 patients with ALS and 8425 control individuals, rs3849942 (p=4·64×10(-10); OR 1·22, 95% CI 1·15-1·30) and rs2814707 (p=4·72×10(-10); 1·22, 1·15-1·30) were associated with ALS.Interpretation: We have found strong evidence of a genetic association of two single nucleotide polymorphisms on chromosome 9 with sporadic ALS, in line with findings from previous independent GWAS of ALS and linkage studies of ALS-frontotemporal dementia. Our findings together with these earlier findings suggest that genetic variation at this locus on chromosome 9 causes sporadic ALS and familial ALS-frontotemporal dementia. Resequencing studies and then functional analysis should be done to identify the defective gene. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
12. Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study.
- Author
-
van Doormaal, Perry T. C., Ticozzi, Nicola, Gellera, Cinzia, Ratti, Antonia, Taroni, Franco, Chiò, Adriano, Calvo, Andrea, Mora, Gabriele, Restagno, Gabriella, Traynor, Bryan J., Birve, Anna, Lemmens, Robin, van Es, Michael A., Saris, Christiaan G. J., Blauw, Hylke M., van Vught, Paul W. J., Groen, Ewout J. N., Corrado, Lucia, Mazzini, Letizia, and Del Bo, Roberto
- Subjects
- *
AMYOTROPHIC lateral sclerosis , *KINESIN , *BIOLOGICAL variation , *COHORT analysis , *GENETIC disorders , *MULTIVARIATE analysis , *PATIENTS - Abstract
Sporadic amyotrophic lateral sclerosis is a multifactorial disease of environmental and genetic origin. In a previous large multicenter genome wide study, common genetic variation in the Kinesin-Associated Protein 3 ( KIFAP3 ) gene (rs1541160) was reported to have a significant effect on survival in amyotrophic lateral sclerosis patients. However, this could not be replicated in 3 smaller independent cohorts. We conducted a large multicenter multivariate survival analysis (n = 2362) on the effect of genetic variation in rs1541160. The previously reported beneficial genotype did not show a significant improvement in survival in this patient group. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
13. Large-scale screening in sporadic amyotrophic lateral sclerosis identifies genetic modifiers in C9orf72 repeat carriers.
- Author
-
Dekker, Annelot M., Seelen, Meinie, van Doormaal, Perry T.C., van Rheenen, Wouter, Bothof, Reinoud J.P., van Riessen, Tim, Brands, William J., van der Kooi, Anneke J., de Visser, Marianne, Voermans, Nicol C., Pasterkamp, R. Jeroen, Veldink, Jan H., van den Berg, Leonard H., and van Es, Michael A.
- Subjects
- *
AMYOTROPHIC lateral sclerosis , *GENETICS of amyotrophic lateral sclerosis , *MOTOR neurons , *NEURODEGENERATION , *NUCLEOTIDE sequencing , *DISEASE risk factors - Abstract
Sporadic amyotrophic lateral sclerosis (ALS) is considered to be a complex disease with multiple genetic risk factors contributing to the pathogenesis. Identification of genetic risk factors that co-occur frequently could provide relevant insight into underlying mechanisms of motor neuron degeneration. To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1 , C9orf72 , TARDBP , FUS , ANG , CHMP2B , ATXN2 , NIPA1 , SMN1 , and UNC13A . We observed sporadic cases with multiple genetic risk variants in 4.1% compared with 1.3% in controls. The overall difference was not in excess of what is to be expected by chance (binomial test, p = 0.59). We did, however, observe a higher frequency than expected of C9orf72 repeat carriers with co-occurring susceptibility variants ( ATXN2 , NIPA1 , and SMN1 ; p = 0.001), which is mainly because of the co-occurrence of NIPA1 repeats in 15% of C9orf72 repeat carriers ( p = 0.006). [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
14. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy.
- Author
-
Seelen, Meinie, Visser, Anne E., Overste, Daniel J., Kim, Hong J., Palud, A., Wong, Tsz H., van Swieten, John C., Scheltens, Philip, Voermans, Nicol C., Baas, Frank, de Jong, J.M.B.V., van der Kooi, Anneke J., de Visser, Marianne, Veldink, Jan H., Taylor, J. Paul, Van Es, Michael A., and van den Berg, Leonard H.
- Subjects
- *
AMYOTROPHIC lateral sclerosis , *GENETIC mutation , *NUCLEOPROTEINS , *FRONTOTEMPORAL dementia , *INCLUSION body myositis , *NEURODEGENERATION , *MOTOR neurons - Abstract
Abstract: Inclusion body myopathy (IBM) associated with Paget disease of the bone, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), sometimes called IBMPFD/ALS or multi system proteinopathy, is a rare, autosomal dominant disorder characterized by progressive degeneration of muscle, brain, motor neurons, and bone with prominent TDP-43 pathology. Recently, 2 novel genes for multi system proteinopathy were discovered; heterogenous nuclear ribonucleoprotein (hnRNP) A1 and A2B1. Subsequently, a mutation in hnRNPA1 was also identified in a pedigree with autosomal dominant familial ALS. The genetic evidence for ALS and other neurodegenerative diseases is still insufficient. We therefore sequenced the prion-like domain of these genes in 135 familial ALS, 1084 sporadic ALS, 68 familial FTD, 74 sporadic FTD, and 31 sporadic IBM patients in a Dutch population. We did not identify any mutations in these genes in our cohorts. Mutations in hnRNPA1 and hnRNPA2B1 prove to be a rare cause of ALS, FTD, and IBM in the Netherlands. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
15. Screening for rare variants in the coding region of ALS-associated genes at 9p21.2 and 19p13.3
- Author
-
Koppers, Max, Groen, Ewout J.N., van Vught, Paul W.J., van Rheenen, Wouter, Witteveen, Esther, van Es, Michael A., Pasterkamp, R. Jeroen, van den Berg, Leonard H., and Veldink, Jan H.
- Subjects
- *
GENETIC testing , *AMYOTROPHIC lateral sclerosis , *NEURODEGENERATION , *MUSCLE weakness , *RESPIRATORY insufficiency , *CAUSES of death - Abstract
Abstract: Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease that causes progressive muscle weakness, eventually resulting in death because of respiratory failure. Genetic variants are thought to predispose to the disease. A recent, large, genome-wide association study identified 2 loci that increase susceptibility to ALS. These 2 loci on chromosomes 9 and 19 consist of 4 genes: UNC13a, IFNK, MOBKL2b, and C9ORF72. A hexanucleotide repeat expansion in the noncoding region of C9ORF72 was recently identified as the cause of chromosome 9-linked ALS-FTD (frontotemporal dementia). In this study, our aim was to determine whether the coding regions of these genes harbor rare, nonsynonymous variants that play a role in ALS pathogenesis. In DNA from 1019 sporadic ALS patients and 1103 control subjects of Dutch descent, we performed a mutation screening analysis in the coding region of these 4 genes by resequencing the exons. A total of 16 amino acid-changing rare variations were identified, 11 in UNC13a and 5 on chromosome 9. Some of these were unique to ALS, but were detected in a single patient. None of the genes showed significant enrichment of rare variants in the coding sequence. Rare variants in the coding region of UNC13a, IFNK, MOBKL2b, and C9ORF72 are unlikely to be a genetic cause of ALS. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
16. H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis
- Author
-
van Rheenen, Wouter, Diekstra, Frank P., van Doormaal, Perry T.C., Seelen, Meinie, Kenna, Kevin, McLaughlin, Russell, Shatunov, Aleksey, Czell, David, van Es, Michael A., van Vught, Paul W.J., van Damme, Philip, Smith, Bradley N., Waibel, Stefan, Schelhaas, H. Jurgen, van der Kooi, Anneke J., de Visser, Marianne, Weber, Markus, Robberecht, Wim, Hardiman, Orla, and Shaw, Pamela J.
- Subjects
- *
GENETIC polymorphisms , *AMYOTROPHIC lateral sclerosis , *DISEASE susceptibility , *BIOACCUMULATION , *PHYSIOLOGICAL effects of iron , *HEMOCHROMATOSIS , *META-analysis - Abstract
Abstract: The H63D polymorphism in HFE has frequently been associated with susceptibility to amyotrophic lateral sclerosis (ALS). Regarding the role of HFE in iron homeostasis, iron accumulation is considered an important process in ALS. Furthermore, novel therapeutic strategies are being developed targeting this process. Evidence for this genetic association is, however, limited to several small studies. For this reason we studied the H63D polymorphism in a large European cohort including 3962 ALS patients and 5072 control subjects from 7 countries. After meta-analysis of previous studies and current findings we conclude that the H63D polymorphism in HFE is not associated with susceptibility to ALS, age at disease onset, or survival. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
17. UNC13A is a modifier of survival in amyotrophic lateral sclerosis
- Author
-
Diekstra, Frank P., van Vught, Paul W.J., van Rheenen, Wouter, Koppers, Max, Pasterkamp, R. Jeroen, van Es, Michael A., Schelhaas, Helenius J., de Visser, Marianne, Robberecht, Wim, Van Damme, Philip, Andersen, Peter M., van den Berg, Leonard H., and Veldink, Jan H.
- Subjects
- *
AMYOTROPHIC lateral sclerosis treatment , *TARGETED drug delivery , *MEDICAL screening , *GENETIC disorders , *NEUROTRANSMITTERS , *GENETIC regulation , *DISEASE susceptibility - Abstract
Abstract: A large genome-wide screen in patients with sporadic amyotrophic lateral sclerosis (ALS) showed that the common variant rs12608932 in gene UNC13A was associated with disease susceptibility. UNC13A regulates the release of neurotransmitters, including glutamate. Genetic risk factors that, in addition, modify survival, provide promising therapeutic targets in ALS, a disease whose etiology remains largely elusive. We examined whether UNC13A was associated with survival of ALS patients in a cohort of 450 sporadic ALS patients and 524 unaffected controls from a population-based study of ALS in The Netherlands. Additionally, survival data were collected from individuals of Dutch, Belgian, or Swedish descent (1767 cases, 1817 controls) who had participated in a previously published genome-wide association study of ALS. We related survival to rs12608932 genotype. In both cohorts, the minor allele of rs12608932 in UNC13A was not only associated with susceptibility but also with shorter survival of ALS patients. Our results further corroborate the role of UNC13A in ALS pathogenesis. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.